Bahrain approves Bharat Biotech's COVAXIN for emergency use
Image Credit: Shortpdia
Bahrain has approved the emergency use of India's indigenously developed COVID-19 vaccination--COVAXIN. "Bahrain's National Health Regulatory Authority @NHRABahrain approves the emergency use of the India's indigenously developed COVID-19 vaccination, COVAXIN by Bharat Biotech," Indian embassy in Bahrain tweeted on Thursday. The approval comes days after Covaxin received the emergency use listing from the WHO.